Autopsy report · NCT06471049

Study Evaluating the Success Rate of Outpatient Management of the Total Benign Hysterectomy by Transvaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) Compared to Each of the Two Laparoscopic Routes (Conventional and Robot-assisted).

“The study was discontinued for practical reasons, due to logistical and organisational constraints (the investigator centre no longer has a surgical robot).”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 5 months before it stopped.
• 1 participant enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Elsan

Sponsor type

University, hospital or other

Conditions

Surgery; Gynecologic Disease

Interventions

Benign Hysterectomy

Participants

1

Sites

1

Countries

France

Trials that died the same way

• A Study of Mitomycin C, Irinotecan, and Cetuximab
  “The study was discontinued due to the death of a co-investigator and a second co-investigator leaving the institution.” (74% match in meaning)
• Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been Treated
  “Study discontinued due to futility.” (73% match in meaning)
• Randomized Controlled Study to Incentivize Doctors for Appropriate Use of Medical Care in NL
  “The study was terminated due to logistical reasons” (71% match in meaning)
• Prospective Comparison of Revolve™ and AuraGen 123 With AuraClens™ in Autologous Fat Grafting to the Breast
  “Study discontinued due to lack of subject follow-up.” (69% match in meaning)
• KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis
  “Study discontinued due to sponsor decision.” (68% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.